A. Vianello

The Fight against COVID-19 on the Multi-Protease Front and Surroundings: Could an Early Therapeutic Approach with Repositioning Drugs Prevent the Disease Severity?

L. Fanucci, A. Vianello, S. Del Turco, 2021, Biomedicines.

Role of matrix metalloproteinases and their tissue inhibitors as potential biomarkers of left ventricular remodelling in the athlete's heart.

P. Pietrini, A. Vianello, L. Caponi, 2009, Clinical science.

Telemonitoring in the Covid-19 Era: The Tuscany Region Experience

M. Donati, L. Fanucci, A. Vianello, 2021, Healthcare.

Aortic valve disease and gamma-glutamyltransferase: accumulation in tissue and relationships with calcific degeneration.

M. C. Epistolato, A. Vianello, A. Paolicchi, 2010, Atherosclerosis.

COVID-19 and cardiovascular consequences: Is the endothelial dysfunction the hardest challenge?

A. Vianello, S. Del Turco, R. Ragusa, 2020, Thrombosis Research.

Circulating soluble receptor for advanced glycation end-product levels are decreased in patients with calcific aortic valve stenosis.

A. Vianello, S. Del Turco, G. Basta, 2010, Atherosclerosis.

Homocysteine in Alzheimer disease and vascular dementia.

M. Gallucci, A. Vianello, A. Zanardo, 2004, Archives of gerontology and geriatrics. Supplement.

β2-Microglobulin and TIMP1 Are Linked Together in Cardiorenal Remodeling and Failure

P. Pietrini, A. Vianello, L. Caponi, 2014, CardioRenal Medicine.

A Multimarker Study of Degenerative Aortic Valve Disease: Stenoinsufficiency Shows More Indices of Bad Prognosis

G. Palladini, M. C. Epistolato, A. Vianello, 2013, Cardiology.